Brain Scanner Shows Infants’ Brains Rehearse Speech Sounds Months Before Their First Words
|
By LabMedica International staff writers Posted on 30 Jul 2014 |

Image: A one-year-old baby sits in a brain scanner, called magnetoencephalography (MEG)—a noninvasive approach to measuring brain activity. The baby listens to speech sounds such as “da” and “ta” played over headphones while researchers record her brain responses (Photo courtesy of the Institute for Learning & Brain Sciences at the University of Washington).
New research in 7- and 11-month-old infants revealed that speech sounds stimulate brain regions that coordinate and plan motor movements for speech. The new study suggests that babies’ brains begin establishing the foundation of how to form words long before they actually begin to speak and this may affect the developmental transition.
Infants notice the difference between sounds of all languages until about eight months of age when their brains begin to concentrate only on the sounds they hear around them. It is not known how this transition occurs, but social interactions and caregivers’ use of embellished “parentese” manner of speech appear to help.
The study’s findings were published July 14, 2014, in the Proceedings of the National Academy of Sciences of the United States of America. “Most babies babble by seven months, but don’t utter their first words until after their first birthdays,” said lead author Dr. Patricia Kuhl, who is the co-director of the University of Washington’s (UW; Seattle, USA) Institute for Learning and Brain Sciences. “Finding activation in motor areas of the brain when infants are simply listening is significant, because it means the baby brain is engaged in trying to talk back right from the start and suggests that seven-month-olds’ brains are already trying to figure out how to make the right movements that will produce words.”
Dr. Kuhl and her research colleagues think this practice at motor planning contributes to the transition when babies become more sensitive to their native language. These findings stress the importance of talking to kids during social interactions even if they are not talking back yet. “Hearing us talk exercises the action areas of infants’ brains, going beyond what we thought happens when we talk to them,” Dr. Kuhl said. “Infants’ brains are preparing them to act on the world by practicing how to speak before they actually say a word.”
In the research, infants sat in a brain scanner that measures brain activation through a noninvasive technique called magnetoencephalography (MEG). The brain scanner resembles an egg-shaped old-fashioned hair dryer and is completely safe for infants. The Institute for Learning and Brain Sciences was the first in the world to use such a tool to study babies while they engaged in a task.
Each of the infants, 57 7- and 11- or 12-month-olds, listened to a series of native and foreign language syllables such as “da” and “ta” as researchers recorded brain responses. They listened to sounds in English and in Spanish. The researchers examined brain activity in an auditory area of the brain called the superior temporal gyrus, as well as in Broca’s area and the cerebellum, cortical regions responsible for planning the motor movements required for producing speech.
This pattern of brain activation occurred for sounds in the seven-month-olds’ native language (English) as well as in a non-native language (Spanish), showing that at this early age infants are responding to all speech sounds, whether or not they have heard the sounds before.
In the older infants, brain activation was different. By 11-12 months, babies’ brains increase motor activation to the non-native speech sounds comparative to their native speech, which the researchers interpret as showing that it takes more effort for the baby brain to forecast which movements create non-native speech. This reflects an effect of experience between 7 and 11 months, and suggests that activation in motor brain areas is contributing to the transition in early speech perception.
The study has social implications, suggesting that the slow and exaggerated-style of parentese speech-- “Hiiiii! How are youuuuu?”--may actually prompt infants to try to synthesize utterances themselves and imitate what they heard, uttering something like “Ahhh bah bah baaah.”
“Parentese is very exaggerated, and when infants hear it, their brains may find it easier to model the motor movements necessary to speak,” Dr. Kuhl said.
Related Links:
University of Washington
Infants notice the difference between sounds of all languages until about eight months of age when their brains begin to concentrate only on the sounds they hear around them. It is not known how this transition occurs, but social interactions and caregivers’ use of embellished “parentese” manner of speech appear to help.
The study’s findings were published July 14, 2014, in the Proceedings of the National Academy of Sciences of the United States of America. “Most babies babble by seven months, but don’t utter their first words until after their first birthdays,” said lead author Dr. Patricia Kuhl, who is the co-director of the University of Washington’s (UW; Seattle, USA) Institute for Learning and Brain Sciences. “Finding activation in motor areas of the brain when infants are simply listening is significant, because it means the baby brain is engaged in trying to talk back right from the start and suggests that seven-month-olds’ brains are already trying to figure out how to make the right movements that will produce words.”
Dr. Kuhl and her research colleagues think this practice at motor planning contributes to the transition when babies become more sensitive to their native language. These findings stress the importance of talking to kids during social interactions even if they are not talking back yet. “Hearing us talk exercises the action areas of infants’ brains, going beyond what we thought happens when we talk to them,” Dr. Kuhl said. “Infants’ brains are preparing them to act on the world by practicing how to speak before they actually say a word.”
In the research, infants sat in a brain scanner that measures brain activation through a noninvasive technique called magnetoencephalography (MEG). The brain scanner resembles an egg-shaped old-fashioned hair dryer and is completely safe for infants. The Institute for Learning and Brain Sciences was the first in the world to use such a tool to study babies while they engaged in a task.
Each of the infants, 57 7- and 11- or 12-month-olds, listened to a series of native and foreign language syllables such as “da” and “ta” as researchers recorded brain responses. They listened to sounds in English and in Spanish. The researchers examined brain activity in an auditory area of the brain called the superior temporal gyrus, as well as in Broca’s area and the cerebellum, cortical regions responsible for planning the motor movements required for producing speech.
This pattern of brain activation occurred for sounds in the seven-month-olds’ native language (English) as well as in a non-native language (Spanish), showing that at this early age infants are responding to all speech sounds, whether or not they have heard the sounds before.
In the older infants, brain activation was different. By 11-12 months, babies’ brains increase motor activation to the non-native speech sounds comparative to their native speech, which the researchers interpret as showing that it takes more effort for the baby brain to forecast which movements create non-native speech. This reflects an effect of experience between 7 and 11 months, and suggests that activation in motor brain areas is contributing to the transition in early speech perception.
The study has social implications, suggesting that the slow and exaggerated-style of parentese speech-- “Hiiiii! How are youuuuu?”--may actually prompt infants to try to synthesize utterances themselves and imitate what they heard, uttering something like “Ahhh bah bah baaah.”
“Parentese is very exaggerated, and when infants hear it, their brains may find it easier to model the motor movements necessary to speak,” Dr. Kuhl said.
Related Links:
University of Washington
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







